These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26304466)

  • 1. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
    Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoxin A
    Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
    Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
    Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
    Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
    Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
    J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
    Figueiredo JC; Levine AJ; Grau MV; Midttun O; Ueland PM; Ahnen DJ; Barry EL; Tsang S; Munroe D; Ali I; Haile RW; Sandler RS; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2136-45. PubMed ID: 18708408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.
    Figueiredo JC; Levine AJ; Grau MV; Barry EL; Ueland PM; Ahnen DJ; Byers T; Bresalier RS; Summers RW; Bond J; McKeown-Eyssen GE; Sandler RS; Haile RW; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2625-31. PubMed ID: 18843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.
    Levine AJ; Grau MV; Mott LA; Ueland PM; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2541-8. PubMed ID: 20841390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
    Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
    Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
    Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
    Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
    Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
    Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
    Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Bond JH; Greenberg ER
    N Engl J Med; 1999 Jan; 340(2):101-7. PubMed ID: 9887161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk.
    Barry EL; Fedirko V; Uppal K; Ma C; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP
    Cancer Prev Res (Phila); 2020 Oct; 13(10):863-876. PubMed ID: 32655007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
    Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
    World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.